Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Teva Pharmaceutical Industries Limited TEVA
$7.99
-$0.22 (-2.74%)
На 18:00, 12 мая 2023
+25.16%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
9819634175.00000000
-
week52high
11.45
-
week52low
6.78
-
Revenue
14925000000
-
P/E TTM
-4
-
Beta
1.18927300
-
EPS
-2.15000000
-
Last Dividend
11.76456700
-
Next Earnings Date
10 мая 2023 г. в 04:00
Описание компании
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| B of A Securities | Buy | Neutral | 05 авг 2022 г. |
| Goldman Sachs | Neutral | Neutral | 02 авг 2022 г. |
| UBS | Neutral | 14 июн 2022 г. | |
| B of A Securities | Neutral | Underperform | 17 мая 2022 г. |
| Goldman Sachs | Neutral | Neutral | 12 мая 2022 г. |
| BMO Capital | Market Perform | Market Perform | 07 ноя 2022 г. |
| JP Morgan | Underweight | Neutral | 14 ноя 2022 г. |
| Piper Sandler | Underweight | Underweight | 23 ноя 2022 г. |
| Jefferies | Hold | Buy | 19 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Zaks Tal Zvi | D | 0 | 12205 | 04 ноя 2022 г. |
| Zaks Tal Zvi | A | 12222 | 12205 | 04 ноя 2022 г. |
| Schultz Kare | D | 0 | 116389 | 01 ноя 2022 г. |
| Schultz Kare | A | 1542471 | 116389 | 01 ноя 2022 г. |
| Kalif Eliyahu Sharon | D | 9376 | 55500 | 22 авг 2022 г. |
| Shani Eli | D | 0 | 1581 | 10 авг 2022 г. |
| Shani Eli | A | 19741 | 1581 | 10 авг 2022 г. |
| Zaks Tal Zvi | A | 15810 | 15810 | 04 авг 2022 г. |
| Satchi-Fainaro Ronit | A | 15810 | 15810 | 04 авг 2022 г. |
| Vergis Janet S. | A | 15810 | 15810 | 04 авг 2022 г. |
Institutional Ownership
Institutional Ownership
| Holder | Shares | Change | Date Reported |
|---|---|---|---|
| DIMENSIONAL FUND ADVISORS LP | 4730246 | -881152 | 30 сент 2022 г. |
| CAPITAL FUND MANAGEMENT S.A. | 937732 | -246878 | 30 сент 2022 г. |
| Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management) | 869411 | 285479 | 30 сент 2022 г. |
| SPHERA FUNDS MANAGEMENT LTD. | 776346 | -3753132 | 30 сент 2022 г. |
| State of New Jersey Common Pension Fund D | 656414 | 0 | 30 сент 2022 г. |
| FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | 350000 | 0 | 30 сент 2022 г. |
| Capricorn Fund Managers Ltd | 284059 | 284059 | 30 сент 2022 г. |
| BOOTHBAY FUND MANAGEMENT, LLC | 201811 | 110263 | 30 июн 2022 г. |
| Davy Global Fund Management Ltd | 141219 | 12889 | 31 дек 2021 г. |
| SOROS FUND MANAGEMENT LLC | 250000 | -160000 | 14 февр 2019 г. |
Новостная лента
Teva Pharma Crumbles After First-Quarter Earnings Miss, Flat Sales
Investors Business Daily
10 мая 2023 г. в 09:15
Teva Pharmaceutical reported lighter-than-expected earnings for the first quarter, leading Teva stock to plunge early Wednesday. The post Teva Pharma Crumbles After First-Quarter Earnings Miss, Flat Sales appeared first on Investor's Business Daily.
Teva Pharmaceutical Is Stabilizing Hinting A Payoff Potential
Seeking Alpha
25 апр 2023 г. в 21:59
Teva Pharmaceutical Is Stabilizing Hinting A Payoff Potential.
Catalyst Pharma And Teva's ANDA Challenge: Firdapse Hangs By A Thread
Seeking Alpha
18 апр 2023 г. в 12:00
Catalyst Pharma And Teva's ANDA Challenge: Firdapse Hangs By A Thread
1 "Safe" Stock to Avoid and 1 to Consider Buying in April
The Motley Fool
15 апр 2023 г. в 08:56
In theory, the stock of companies that make generic drugs have the potential to be safe investments. Despite that, companies like Teva Pharmaceuticals aren't actually safe at all.
Teva to Host Conference Call to Discuss First Quarter 2023 Financial Results at 8 a.m. ET on May 10, 2023
Business Wire
14 апр 2023 г. в 16:15
TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its first quarter 2023 financial results on Wednesday, May 10, 2023 at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day, at 8:00 a.m. ET. In order to participate, please register in advance here to obtain a local or toll-free phone number and your personal pin.